Implican Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $10.9M

  • Investors
  • 6

Implican General Information

Description

Developer of an anastomotic device designed to reduce anastomotic leakage. The company's device is based on compression and fixation of the bowel wall with the use of two rings, and using this compression, the wound will heal by primary intent, resulting in reduced anastomotic leakage, enabling surgeons to reduce complications during abdominal surgery.

Contact Information

Website
www.implican.nl
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • L.J.Zielstraweg 2
  • 9713 GX Groningen
  • Netherlands
+31 06
Primary Industry
Surgical Devices
Vertical(s)
Corporate Office
  • L.J.Zielstraweg 2
  • 9713 GX Groningen
  • Netherlands
+31 06

Implican Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Implican Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A) 10-Apr-2025 $10.9M Completed Generating Revenue
7. Grant 01-May-2024 Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2024 Completed Startup
5. Seed Round Cancelled Startup
4. Grant 01-Nov-2023 Completed Startup
3. Seed Round 01-Nov-2022 Completed Startup
2. Grant 01-Jan-2021 $48.7K Completed Startup
1. Grant 01-Jan-2020 $22.2K Completed Startup
To view Implican’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Implican Patents

Implican Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3233316-A1 Device for performing anastomosis Pending 28-Sep-2021
EP-4408306-A1 Device for performing anastomosis Pending 28-Sep-2021
US-20250049438-A1 Device for performing anastomosis Pending 28-Sep-2021
WO-2023055232-A1 Device for performing anastomosis Inactive 28-Sep-2021
CA-3045605-A1 Instrument for performing anastomosis Pending 02-Dec-2016 A61B17/1114
To view Implican’s complete patent history, request access »

Implican Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Implican Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
EUREKA Eurostars Government
Medlim Accelerator/Incubator
Hanzepoort Venture Capital Minority
Nextgen Ventures Venture Capital Minority
Noordelijke Ontwikkelings Maatschappij PE/Buyout Minority
You’re viewing 5 of 6 investors. Get the full list »

Implican FAQs

  • When was Implican founded?

    Implican was founded in 2016.

  • Where is Implican headquartered?

    Implican is headquartered in Groningen, Netherlands.

  • What is the size of Implican?

    Implican has 5 total employees.

  • What industry is Implican in?

    Implican’s primary industry is Surgical Devices.

  • Is Implican a private or public company?

    Implican is a Private company.

  • What is Implican’s current revenue?

    The current revenue for Implican is .

  • How much funding has Implican raised over time?

    Implican has raised $11.9M.

  • Who are Implican’s investors?

    EUREKA Eurostars, Medlim, Hanzepoort, Nextgen Ventures, and Noordelijke Ontwikkelings Maatschappij are 5 of 6 investors who have invested in Implican.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process